Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $115.82 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $62.31 | 3 | $0 (2018) |
| AbbVie Inc. | $35.79 | 1 | $0 (2021) |
| GENZYME CORPORATION | $17.72 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $17.72 | 1 | GENZYME CORPORATION ($17.72) |
| 2021 | $35.79 | 1 | AbbVie Inc. ($35.79) |
| 2018 | $43.64 | 2 | Otsuka America Pharmaceutical, Inc. ($43.64) |
| 2017 | $18.67 | 1 | Otsuka America Pharmaceutical, Inc. ($18.67) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/11/2022 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Rheumatology | ||||||
| 09/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $35.79 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: PSYCHIATRY | ||||||
| 02/16/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 7 | 105 | 1,118 | $64,704 | $20,779 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 16 | 960 | $19,200 | $14,344 | 74.7% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 11 | 55 | $39,765 | $5,098 | 12.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 20 | $3,200 | $697.91 | 21.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 20 | 20 | $800.00 | $199.32 | 24.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 14 | 25 | $675.00 | $191.21 | 28.3% |
| 80076 | Liver function blood test panel | Office | 2020 | 13 | 19 | $646.00 | $152.99 | 23.7% |
| 82565 | Blood creatinine level | Office | 2020 | 13 | 19 | $418.00 | $95.88 | 22.9% |
About Dr. John Rice, M.D
Dr. John Rice, M.D is a Rheumatology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336223239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Rice, M.D has received a total of $115.82 in payments from pharmaceutical and medical device companies, with $17.72 received in 2022. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($115.82).
As a Medicare-enrolled provider, Rice has provided services to 105 Medicare beneficiaries, totaling 1,118 services with total Medicare billing of $20,779. Data is available for 1 year (2020–2020), covering 7 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Durham, NC
- Active Since 10/25/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1336223239
Products in Payments
- REXULTI (Drug) $62.31
- UBRELVY (Drug) $35.79
- KEVZARA (Biological) $17.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Durham
Ralph Snyderman, M.d, M.D
Rheumatology — Payments: $1.7M
Joseph Shanahan, Md, MD
Rheumatology — Payments: $762,544
Virginia Kraus
Rheumatology — Payments: $500,154
Megan Clowse
Rheumatology — Payments: $137,567
Laura Schanberg, M.d, M.D
Rheumatology — Payments: $42,792
Tony Ning, Md, MD
Rheumatology — Payments: $15,743